Paper7585571
p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
Waldman T and 2 others. Cancer Res, 1995. Cited by 1,178 papers, by iCite.
Cite this record
ConductScience Library. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Papers, record 7585571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7585571
- Cell line
- HCT 116 CDKN1A(-/-)3 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Source Cell lines
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colonic Neoplasms | Major topic |
| Cyclins | Major topic |
| G1 Phase | Major topic |
| Genes, p53 | Major topic |
| Cyclin-Dependent Kinase Inhibitor p21 | |
| DNA Damage | |
| Humans | |
| Tumor Cells, Cultured |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA43460 | NCI NIH HHS | United States | R01CA043460 | PubMed and NIH | NIH RePORTER |
| GM07184 | NIGMS NIH HHS | United States | PubMed | PubMed | |
| R37CA043460 | NIH | NIH RePORTER |
Cited by499
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,178 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42247504 | Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancers. | Sci Adv | 2026 | https://conductscience.org/library/papers/42247504 | PubMed |
| 42214331 | Molecular mechanisms of the MLL4 complex in H3K4 methylation and p53-dependent transcription activation. | Mol Cell | 2026 | https://conductscience.org/library/papers/42214331 | PubMed |
| 42208898 | Reciprocal compensation of caspase-2 and p53 regulates the DNA damage response in HCT116 colon cancer cells. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42208898 | PubMed |
| 42058559 | γ-Aminobutyric acid enhances myogenesis and heat/cold stress resistance in bovine muscle satellite cells. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42058559 | PubMed |
| 41976280 | p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code? | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976280 | PubMed |
| 41901340 | Curcumin in High Doses Reverses the UV-B-Induced DNMT and HDAC Upregulation In Vitro: A Novel Anti-Cancer Approach? | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901340 | PubMed |
| 41842937 | p53-induced RNA-binding protein ZMAT3 inhibits transcription of a hexokinase to suppress mitochondrial respiration in human cancer cells. | Elife | 2026 | https://conductscience.org/library/papers/41842937 | PubMed |
| 41669326 | Long noncoding RNA LOC441461 drives cancer growth and is associated with poor clinical outcomes. | Tzu Chi Med J | 2026 | https://conductscience.org/library/papers/41669326 | PubMed |
| 41332727 | Dual RNA Polymerase I Inhibition with CX-5461 and BMH-21 Synergizes in Breast Cancer by Activating p53-Dependent Stress. | bioRxiv | 2025 | https://conductscience.org/library/papers/41332727 | PubMed |
| 40970066 | Zinc Transporters and MTF1-Notch1-P21 Signalling Axis in TPEN-Induced Cell Death in Human Skeletal Muscle (Rhabdomyosarcoma) Cells. | Cureus | 2025 | https://conductscience.org/library/papers/40970066 | PubMed |
| 40867560 | Exploring the Antioxidant Roles of Cysteine and Selenocysteine in Cellular Aging and Redox Regulation. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867560 | PubMed |
| 40841483 | BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/40841483 | PubMed |
| 40524430 | The TP53 tumor suppressor gene: From molecular biology to clinical investigations. | J Intern Med | 2025 | https://conductscience.org/library/papers/40524430 | PubMed |
| 40347943 | Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality. | Cell Genom | 2025 | https://conductscience.org/library/papers/40347943 | PubMed |
| 40340905 | Cocultured amniotic stem cells and cardiomyocytes in a 3-D acellular heart patch reduce the infarct size and left ventricle remodeling: promote angiogenesis in a porcine acute myocardial infarction model. | J Cardiothorac Surg | 2025 | https://conductscience.org/library/papers/40340905 | PubMed |
| 39959743 | The edible ethanol extract of Rosa hybrida suppresses colon cancer progression by inhibiting the proliferation-cell signaling-metastasis axis. | Nutr Res Pract | 2025 | https://conductscience.org/library/papers/39959743 | PubMed |
| 39861126 | Ruthenium(II) Complex with 1-Hydroxy-9,10-Anthraquinone Inhibits Cell Cycle Progression at G0/G1 and Induces Apoptosis in Melanoma Cells. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/39861126 | PubMed |
| 39250704 | Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules. | ACS Chem Biol | 2024 | https://conductscience.org/library/papers/39250704 | PubMed |
| 38951700 | Determinants of p53 DNA binding, gene regulation, and cell fate decisions. | Cell Death Differ | 2024 | https://conductscience.org/library/papers/38951700 | PubMed |
| 38842658 | S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway. | In Vitro Cell Dev Biol Anim | 2024 | https://conductscience.org/library/papers/38842658 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCNL2 | 81669 | PubTator's text mining | https://conductscience.org/library/genes/81669 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7585571
GET https://conductscience.org/api/papers/v1/7585571/cited_by?page=2